Deutsche Bank is out with its report today on Stryker SYK, maintaining Hold.
In a note to clients, Deutsche Bank writes, "Hill-Rom HRC hosted an investor day on Tuesday providing its long-range plan and views on the market HRC competes with Stryker's Medical franchise (8% of total sales), which manufactures beds, bed frames, stretchers, and patient handling devices for acute and specialty care facilities. We estimate SYK is No. 2 in share behind HRC. HRC commented it expected the overall bed market sales growth in the low-tomid single digits, consistent with the current environment. Nothing changed our view as it relates to SYK shares (we rate Hold)."
Deutsche Bank maintains a $61 PT on SYK.
Shares of SYK closed Tuesday at $62.74, down 0.49% from Monday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in